Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Cardiology-CTVS
  • Cardiology & CTVS News
  • Clopidogrel resistance...

Clopidogrel resistance associated with gene polymorphism tied to adverse clinical outcomes following PCI: Study

Written By : Medha Baranwal |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2024-08-09T09:00:36+05:30  |  Updated On 9 Aug 2024 12:55 PM IST
Clopidogrel resistance associated with gene polymorphism tied to adverse clinical outcomes following PCI: Study
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: Recent studies have reported a concerning issue in managing Acute Coronary Syndrome (ACS)-clopidogrel resistance. This phenomenon, where patients exhibit a reduced response to the antiplatelet medication clopidogrel, poses significant challenges to optimal patient care and clinical outcomes.

A recent study published in the Indian Heart Journal has emphasized the association between gene polymorphisms, clopidogrel resistance, and negative clinical outcomes after percutaneous coronary intervention (PCI).

Clopidogrel is a cornerstone in ACS treatment, helping to prevent thrombotic events by inhibiting platelet aggregation. CYP2C19 is a highly polymorphic enzyme that leads to varied responses to clopidogrel in ACS patients. Variants that result in loss of function (LOF) are linked to decreased efficacy or a complete lack of activity for clopidogrel. The relationship between LOF variants and reduced platelet inhibition has significant clinical implications. Factors such as patient demographics, genetic variations, and drug interactions are essential for understanding individual responses to clopidogrel.

In India, the prevalence of clopidogrel resistance ranges from 5% to 44%. Ischemic and bleeding events risk can be significantly minimized by tailoring antiplatelet therapy based on platelet function testing (PFT), genetic profiles, and clinical characteristics, the researchers noted.

Against the above background, Heemanshu Lodhi, Department of Cardiology, Army Hospital Research and Referral, Delhi Cantonment, New Delhi, and colleagues aimed to assess the association between CYP2C19 metabolization status and clopidogrel resistance by PFT based on platelet reactivity units (PRUs).

The study included 668 individuals undergoing PCI, approved by the Institutional Review Board (IRB) with informed consent. Samples were collected per ICMR and AHRR guidelines, focusing on patients with acute coronary syndrome based on criteria from previous studies. Eligible participants were those willing to undergo follow-up assessments. DNA was isolated using the QIAGEN DNA Mini Kit, and platelet function was evaluated using the Verify PRU test according to the manufacturer’s protocol.

The key findings of the study were as follows:

  • 54.64% of the patients who carried the LOF variants were categorized as poor metabolizers for clopidogrel, while the rest individuals belong to ultra (18.26%) and extensive (27.1%) metabolizers.
  • To examine the association between genetic testing results related to clopidogrel metabolization status and PRU values, platelet function testing (PFT) was randomly conducted for 143 individuals, of whom 45%, 12%, and 43% exhibited good, intermediate, and poor drug effects, respectively.
  • There was a significant statistical correlation between genetic test results and PRU values with an Odds ratio (OR) of 10.4.
  • In TVR and TLR cases, 75% and 88.85% were clopidogrel resistant (Intermediate Metabolizers and Poor Metabolizers) respectively.
  • 88.80% of the individuals had PRU values above 160, indicating increased platelet reactivity in TLR individuals.
  • Among patients with ISR, 80% had PRU values above 160, and 80% were clopidogrel resistant.
  • All individuals with stent thrombosis were clopidogrel resistant, and 100% had PRU values above 160.
  • Twelve patients died due to cardiovascular disease, 75% were clopidogrel resistant, and 83.32% had more than 160 PRU values.

"The study demonstrates the association between CYP2C19 LOF polymorphisms and adverse clinical outcomes in ACS patients following PCI. This emphasizes the need for personalized treatment approaches based on genetic findings to optimize antiplatelet therapy and enhance patient outcomes," the researchers concluded.

Reference:

Lodhi, H., Bhat, K. G., Guleria, V. S., Pillai, R. K. J., Goel, R., Sharma, N., Sharma, A., & Sharma, V. (2024). Clopidogrel Resistance and its effect on clinical outcomes in Acute Coronary Syndrome. Indian Heart Journal. https://doi.org/10.1016/j.ihj.2024.07.003


Indian Heart Journalacute coronary syndromeCYP2C19clopidogrel resistancePCI
Source : Indian Heart Journal
Medha Baranwal
Medha Baranwal

    MSc. Biotechnology

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    Prediabetes and the Mind: Unraveling Cognitive and Mental Health Risks

    Prediabetes and the Mind: Unraveling Cognitive and Mental Health Risks

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    View All

    Journal Club Today

    Universal Heart Health Advice Ignores Realities in Low-Income Countries: Study Finds

    Universal Heart Health Advice Ignores Realities in Low-Income Countries: Study Finds

    View All

    Health News Today

    Health Bulletin 24/May/2025

    Health Bulletin 24/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok